---
title: "Terns Pharmaceuticals (TERN.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TERN.US/norm.md"
symbol: "TERN.US"
name: "Terns Pharmaceuticals"
parent: "https://longbridge.com/en/quote/TERN.US.md"
datetime: "2026-05-20T12:24:22.140Z"
locales:
  - [en](https://longbridge.com/en/quote/TERN.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TERN.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TERN.US/norm.md)
---

# Terns Pharmaceuticals (TERN.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.2407 | -0.2686 | -0.2631 | -0.2614 | -0.2389 |
| ROE | -14.61% | -33.44% | -30.53% | -28.47% | -24.55% |
| Revenue | - | - | - | - | - |
| Net income | -23.57M | -24.64M | -24.09M | -23.91M | -21.80M |

## Balance Sheet (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 1.03B | 301.65M | 320.42M | 339.31M | 363.93M |
| Leverage | 1.02 | 1.06 | 1.05 | 1.04 | 1.05 |
| BVPS | 8.96 | 3.25 | 3.49 | 3.73 | 3.97 |
| Turnover | - | - | - | - | - |

## Cash Flow Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -19.08M | -19.77M | -18.88M | -24.44M | -14.58M |
| Investing CF | -350.00M | 24.50M | 25.50M | 1.96M | -94.35M |
| Financing CF | 743.12M | 0.0000 | 324000.00 | 68000.00 | 304000.00 |
| Free CF | -13.33M | -12.57M | -12.04M | -17.55M | -9.12M |